Get started
Author

Denis S. Burminskiy

Observed names: D. Burminskiy, D. S. Burminskiy, D.S. Burminskiy, D.S. Burminsky, Denis Burminskiy, Denis S. Burminskii
ORCID: 0000-0001-7098-2570
Observed ORCID: 0000-0001-7098-2570
OpenAlex ID: A5072175779
Add-on clinical effects of selective antagonist of 5HT6 receptors AVN-211 (CD-008-0173) in patients with schizophrenia stabilized on antipsychotic treatment: pilot study
2013 · Margarita A. Morozova, Taisiya A. Lepilkina, et al. · CNS Spectrums · 41
Platelet glutamate dehydrogenase activity and efficacy of antipsychotic therapy in patients with schizophrenia
2019 · Olga K. Savushkina, Elena B. Tereshkina, et al. · Journal of Medical Biochemistry · 19
PDF
5-HT6 Receptor Antagonist as an Adjunct Treatment Targeting Residual Symptoms in Patients With Schizophrenia
2017 · Margarita Morozova, Denis Burminskiy, et al. · Journal of Clinical Psychopharmacology · 19
Safety and efficacy of aviandr in patients with generalized anxiety disorder: A multicenter, randomized, double-blind, placebo-controlled, dose-finding, pilot study
2021 · Andrey A. Ivashchenko, Margarita A. Morozova, et al. · Journal of Psychiatric Research · 14
The activity of erythrocyte and platelet glutathione reductase and glutathione-S-transferase in paranoid schizophrenia
2018 · O. K. Savushkina, I. S. Boksha, et al. · S S Korsakov Journal of Neurology and Psychiatry · 5
Guideline for the use of therapeutic drug monitoring of antipsychotics to individualize the selection of therapy in the treatment of exacerbation of schizophrenia
2023 · S. S. Potanin, M. M. Morozova, et al. · V M BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY · 4
PDF
Treatment Response and GWAS Risk Allele rs2514218 (C) of the Dopamine D2 Receptor Gene in Inpatients with Schizophrenia
2021 · Margarita A. Morozova, Tatyana V. Lezheiko, et al. · Neuropsychobiology · 4
Low doses of quetiapine (Seroquel) as an impulsivity corrector in patients with bipolar affective disorder in remission
2022 · M.A. Morozova, S.S. Potanin, et al. · S S Korsakov Journal of Neurology and Psychiatry · 3
Emotional Attribution in a Social Context in Stable Patients with Schizophrenia with Residual Psychotic Symptoms
2025 · Margarita A. Morozova, Evgenia Yu. Nikonova, et al. · National Psychological Journal · 2
PDF
Impulsivity in schizophrenia: phenomenology and research approaches
2025 · T. A. Lepilkina, M. A. Morozova, et al. · V M BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY · 1
PDF
The Relationship between Treatment Response in Patients with Acute Psychotic Episodes of Schizophrenia and the Activity of Their Platelet Enzymes
2023 · M. A. Morozova, D. S. Burminskiy, et al. · Psikhiatriya · 1
PDF
Variants of changes in the psychopathological phenomenology of the long-term remission in stable patients with attack-like progressive form of schizophrenia: a longitudinal study
2015 · M. A. Morozova, D. S. Burminskiy, et al. · S S Korsakov Journal of Neurology and Psychiatry · 1
Plasma levels of antipsychotics and the severity of side-effects in the treatment of schizophrenia exacerbation
2015 · S. S. Potanin, D. S. Burminskiy, et al. · S S Korsakov Journal of Neurology and Psychiatry · 1
The influence of impulsivity on the clinical symptoms and therapeutic response in generalized anxiety disorder: the role of comorbid mental disorders
2025 · S. S. Potanin, M. A. Morozova, et al. · V M BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY
PDF
Impaired Impulse Control in Patients with Paranoid Schizophrenia in a State of Long-Term Drug Remission (Exploratory Research)
2025 · D. S. Burminskiy, M. A. Morozova, et al. · Psikhiatriya
PDF
Self-Assessment of Impulsivity in Patients with Paranoid Schizophrenia in Exacerbation and Remission
2024 · M. A. Morozova, E. Yu. Nikonova, et al. · Psikhiatriya
The technology of induction of physiological ketosis in asthenia of various origins and decreased resistance to cognitive and physical activity
2024 · M.A. Morozova, A.G. Beniashvili, et al. · S S Korsakov Journal of Neurology and Psychiatry
Unique combination of herbal ingredients for everyday distress in medical workers (short-term pilot study)
2022 · M. Morozova, A. Alexeev, et al. · European Psychiatry
PDF
Primary clinical testing of the questionnaire “Brief questionary of quality of anxiety” in patients with generalized anxiety disorder
2022 · M. Morozova, G. Rupchev, et al. · European Psychiatry
PDF
Effects of Blockade of Cholinesterase on Negative Disorders in Schizophrenia
2022 · M. A. Morozova, S. S. Potanin, et al. · Neuroscience and Behavioral Physiology
Improvement of conventional perception in stable patients with schizophrenia by add-on treatment with ipidacrine
2021 · M. Morozova, S. Potanin, et al. · European Psychiatry
PDF
An effect of cholinesterase blockade on negative symptoms in schizophrenia
2021 · M.A. Morozova, S.S. Potanin, et al. · S S Korsakov Journal of Neurology and Psychiatry
Interaction of Symptoms and Cognitive Dysfunction in Remitted Schizophrenic Patients With and Without Residua – Important Sign of Heterogeneity for Design of Cognitive Enhancer Studies
2017 · G. Rupchev, M. Morozova, et al. · European Psychiatry
PDF
Positive changes in the severity of residual psychotic symptoms in schizophrenic patients switched to treatment with risperidone
2017 · D. S. Burminskiy, M. A. Morozova · S S Korsakov Journal of Neurology and Psychiatry
Variants of changes in the psychopathological phenomenology of the long-term remission in stable patients with paranoid schizophrenia: a longitudinal study
2015 · Morozova Ma, D. S. Burminskiy, et al.
Works count: 26
Citation count: 114
H-index: 5
I10-index: 4
Year
Topic
Type